CAS 2734167-68-9

1H-Indazole-6-carbonitrile, 3-(1,2,3,4,4a,5-hexahydro-3-methylpyrazino[2,1-c][1,4]benzoxazin-8-yl)-5-(2-methoxyphenyl)-

Description:

1H-Indazole-6-carbonitrile, 3-(1,2,3,4,4a,5-hexahydro-3-methylpyrazino[2,1-c][1,4]benzoxazin-8-yl)-5-(2-methoxyphenyl)- is a complex organic compound characterized by its unique structural features, including an indazole core, a carbonitrile functional group, and a substituted pyrazino-benzoxazine moiety. This compound exhibits potential biological activity, which may include interactions with various biological targets, making it of interest in medicinal chemistry. The presence of the methoxyphenyl group suggests potential for lipophilicity, which can influence its pharmacokinetic properties. Additionally, the hexahydro structure indicates a saturated ring system that may contribute to its stability and reactivity. The compound's molecular interactions, solubility, and stability under various conditions are essential for understanding its applications in drug development. As with many complex organic molecules, the synthesis and characterization of this compound would require advanced techniques such as NMR spectroscopy, mass spectrometry, and crystallography to confirm its structure and purity.

Formula: C₂₇H₂₅N₅O₂

Synonyms:

• HPK1-IN-11
• 1H-Indazole-6-carbonitrile, 3-(1,2,3,4,4a,5-hexahydro-3-methylpyrazino[2,1-c][1,4]benzoxazin-8-yl)-5-(2-methoxyphenyl)-

HPK1-IN-11

CAS: 2734167-68-9

HPK1-IN-11 is a potent HPK1 inhibitor. HPK1-IN-11 has potential for the study of HPK1-related diseases.

Formula: C₂₇H₂₅N₅O₂

Color and Shape: Solid

Molecular weight: 451.52

Ref: TM-T62742